FDA Inspection 632170 — Merz Pharmaceuticals GmbH
The FDA completed an inspection of Merz Pharmaceuticals GmbH on Nov 12, 2009 in Frankfurt Am Main. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 12, 2009
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Frankfurt Am Main (Germany)
Additional Details
Sponsor, Contract Research Organization